Neurovalens Limited
6 News & Press Releases found

Neurovalens Limited news

The University of California recently awarded UC San Diego entrepreneur Jason McKeown for his wearable weight loss technology company Neurovalens, UC announced Monday.

McKeown was one of 12 finalists in the third annual UC Entrepreneur Pitch Competition. Six early-stage biotechnology startups and six late-stage biotech businesses were selected to present their pitches at last week’s 2019 Global Corporate Venturing and Innovation Summit. According to UC officials, nearly 1

Dec. 28, 2022

An estimated 415 million people are living with diabetes in the world.

Diabetes is a chronic disease, that causes blood sugar levels in your body to become too high, either due to your body not being able to respond properly to insulin or due to your body not being unable to produce any at all. If left untreated, this can lead to serious complications such as heart attack, stroke, obesity, eye disease, kidney disease and nerve damage.

World Diabetes D

Nov. 18, 2022

These are the start-ups that most impressed Britain’s top entrepreneurs and investors in 2019. There was a technology theme to the selections, while several on our panel of small business champions picked companies, they claimed were tackling some of the world’s biggest problems by treating Alzheimer’s disease and broadening access to education.

Jan. 21, 2022

Neurovalens has been boosted by £750,000 from the Growth Finance Fund to support the launch of a new sleep product in the USA later this year.

In September the company, founded by Dr Jason McKeown in 2015 and which has already secured £4.6 million from a number of equity investors, was offered £1 million from Invest NI for its new research and development programme in a move it said would add 22 jobs (it currently has 26 staff).

Of the latest funding b

Jan. 21, 2022

Neurovalens, a global leader of neuro-technology products, is embarking on the development of a device for the treatment of obesity with £1m support from Invest NI. The technology is based on the neuro stimulation of specific areas of the brain responsible for influencing appetite and cravings.

The company specialises in combining neuroscience and technology to tackle global health challenges such as obesity, diabetes and sleep disorders. The research and development gran

Jan. 21, 2022

The product, Modius, claims to stimulate the part of the brain that controls fat storage and metabolism.

The company, Modius Health, was set up by neuroscientist Dr Jason McKeown from Portglenone, County Antrim in 2013.

Modius has made the top 10 in the Last Gadget Standing awards at the Consumer Electronics Show (CES) in Las Vegas.

The winning gadget will be decided by vote on Thursday.

Electrical pulse
The Las Vegas conference attracts 4

Jan. 13, 2022